Syntara Limited
Manufacturing · Australia · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Po Box, Frenchs Forest, New South Wales,...Phone Number
+61 294547200Website
www.syntaratx.com.auRevenue
$6.2 MillionStock Symbol
SNTIndustry
About Syntara Limited
Syntara is a clinical-stage drug development company focused on creating innovative treatments for blood-related cancers and conditions associated with inflammation and fibrosis. The company specializes in addressing extracellular matrix dysfunction through its expertise in amine oxidase chemistry. Its lead candidate, amsulostat, is currently undergoing Phase 2 trials for myelofibrosis, with additional studies in myelodysplastic syndrome and other chronic diseases. Syntara aims to provide effective therapies for patients with high unmet medical needs in hematological malignancies and related conditions.Explore more
SIC Code 28,283NAICS Code 32,325Ticker ASX: SNTShow moreSyntara Limited Org Chart
Compare Similar Companies to Syntara Limited
Compare insights from companies similar to Syntara Limited, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Top Manufacturing Companies
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Syntara Limited
Sign Up For FreeTo access detailed company insights
Syntara is a clinical-stage drug development company focused on creating innovative treatments for blood-related cancers and conditions associated with inflammation and fibrosis. The company specializes in addressing extracellular matrix dysfunction through its expertise in amine oxidase chemistry. Its lead candidate, amsulostat, is currently under... Read More